BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 11123432)

  • 1. Effective cancer targeting using an anti-tumor tissue vascular endothelium-specific monoclonal antibody (TES-23).
    Wakai Y; Matsui J; Koizumi K; Tsunoda S; Makimoto H; Ohizumi I; Taniguchi K; Kaiho S; Saito H; Utoguchi N; Tsutsumi Y; Nakagawa S; Ohsugi Y; Mayumi T
    Jpn J Cancer Res; 2000 Dec; 91(12):1319-25. PubMed ID: 11123432
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Targeting therapy using a monoclonal antibody against tumor vascular endothelium].
    Tsunoda S; Tsutsumi Y; Nakagawa S; Mayumi T
    Yakugaku Zasshi; 2000 Mar; 120(3):256-64. PubMed ID: 10723267
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Specific binding of TES-23 antibody to tumour vascular endothelium in mice, rats and human cancer tissue: a novel drug carrier for cancer targeting therapy.
    Tsunoda S; Ohizumi I; Matsui J; Koizumi K; Wakai Y; Makimoto H; Tsutsumi Y; Utoguchi N; Taniguchi K; Saito H; Harada N; Ohsugi Y; Mayumi T
    Br J Cancer; 1999 Dec; 81(7):1155-61. PubMed ID: 10584876
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor vascular targeting using a tumor-tissue endothelium-specific monoclonal antibody as an effective strategy for cancer chemotherapy.
    Makimoto H; Koizumi K; Tsunoda S; Wakai Y; Matsui J; Tsutsumi Y; Nakagawa S; Ohizumi I; Taniguchi K; Saito H; Utoguchi N; Ohsugi Y; Mayumi T
    Biochem Biophys Res Commun; 1999 Jul; 260(2):346-50. PubMed ID: 10403773
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suppression of solid tumor growth by a monoclonal antibody against tumor vasculature in rats: involvement of intravascular thrombosis and fibrinogenesis.
    Ohizumi I; Taniguchi K; Saito H; Kawata H; Tsunoda S; Makimoto H; Wakai Y; Tsutsumi Y; Nakagawa S; Utoguchi N; Kaiho S; Ohsugi Y; Mayumi T
    Int J Cancer; 1999 Sep; 82(6):853-9. PubMed ID: 10446453
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of tumor vascular antigens by monoclonal antibodies prepared from rat-tumor-derived endothelial cells.
    Ohizumi I; Tsunoda S; Taniguchi K; Saito H; Esaki K; Koizumi K; Makimoto H; Wakai Y; Matsui J; Tsutsumi Y; Nakagawa S; Utoguchi N; Ohsugi Y; Mayumi T
    Int J Cancer; 1998 Aug; 77(4):561-6. PubMed ID: 9679759
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Local administration of monoclonal antibody-drug conjugate: a new strategy to reduce the local recurrence of colorectal cancer.
    Kitamura K; Takahashi T; Kotani T; Miyagaki T; Yamaoka N; Tsurumi H; Noguchi A; Yamaguchi T
    Cancer Res; 1992 Nov; 52(22):6323-8. PubMed ID: 1423277
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapy with unlabeled and 131I-labeled pan-B-cell monoclonal antibodies in nude mice bearing Raji Burkitt's lymphoma xenografts.
    Buchsbaum DJ; Wahl RL; Normolle DP; Kaminski MS
    Cancer Res; 1992 Dec; 52(23):6476-81. PubMed ID: 1423295
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radiolabeled monoclonal antibodies specific to the extracellular domain of prostate-specific membrane antigen: preclinical studies in nude mice bearing LNCaP human prostate tumor.
    Smith-Jones PM; Vallabhajosula S; Navarro V; Bastidas D; Goldsmith SJ; Bander NH
    J Nucl Med; 2003 Apr; 44(4):610-7. PubMed ID: 12679407
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radioimmunotherapy of human colon cancer xenografts using a dimeric single-chain Fv antibody construct.
    Pavlinkova G; Booth BJ; Batra SK; Colcher D
    Clin Cancer Res; 1999 Sep; 5(9):2613-9. PubMed ID: 10499640
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and specificity of a monoclonal antibody-drug conjugate in chemotherapy by intratumoral injection.
    Kitamura K; Takahashi T; Miyagaki T; Yamaoka N; Tsurumi H; Ohtsuji E; Kamiguchi M; Noguchi A; Yamaguchi T
    Jpn J Cancer Res; 1992 Jul; 83(7):769-74. PubMed ID: 1387634
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibody-based therapy targeting tumor vascular endothelial cells suppresses solid tumor growth in rats.
    Ohizumi I; Tsunoda S; Taniguchi K; Saito H; Esaki K; Makimoto H; Wakai Y; Tsutsumi Y; Nakagawa S; Utoguchi N; Kaiho S; Ohsugi Y; Mayumi T
    Biochem Biophys Res Commun; 1997 Jul; 236(2):493-6. PubMed ID: 9240467
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recognition of human activated CD44 by tumor vasculature-targeted antibody.
    Taniguchi K; Harada N; Ohizumi I; Tsutsumi Y; Nakagawa S; Kaiho Si; Mayumi T
    Biochem Biophys Res Commun; 2000 Mar; 269(3):671-5. PubMed ID: 10720474
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapy of rat tracheal carcinoma IC-12 in SCID mice: vascular targeting with [213Bi]-MAb TES-23.
    Kennel SJ; Lankford T; Davern S; Foote L; Taniguchi K; Ohizumi I; Tsutsumi Y; Nakagawa S; Mayumi T; Mirzadeh S
    Eur J Cancer; 2002 Jun; 38(9):1278-87. PubMed ID: 12044516
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased serum stability and prolonged biological half-life of neocarzinostatin covalently bound to monoclonal antibodies.
    Gottschalk U; Garnett MC; Ward RK; Maibücher A; Köhnlein W
    J Antibiot (Tokyo); 1991 Oct; 44(10):1148-54. PubMed ID: 1835456
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intratumoral administration of neocarzinostatin conjugated to monoclonal antibody A7 in a model of pancreatic cancer.
    Otsuji E; Yamaguchi T; Yamaoka N; Kitamura K; Yamaguchi N; Takahashi T
    J Surg Oncol; 1993 Aug; 53(4):215-9. PubMed ID: 8393501
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preclinical evaluation of chimeric L6 antibody for the treatment of Kaposi's sarcoma with radioimmunotherapy.
    Leigh BR; Burke PA; Hong AM; O'Donnell RT; Howell LP; Miers LA; DeNardo GL; DeNardo SJ
    Cancer Biother Radiopharm; 1999 Apr; 14(2):113-9. PubMed ID: 10850294
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimizing radioimmunotherapy by matching dose distribution with tumor structure using 3D reconstructions of serial images.
    Flynn AA; Pedley RB; Green AJ; Boxer GM; Boden R; Begent RH
    Cancer Biother Radiopharm; 2001 Oct; 16(5):391-400. PubMed ID: 11776756
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distribution of neocarzinostatin conjugated to biotinylated chimeric monoclonal antibody Fab fragments after administration of avidin.
    Otsuji E; Yamaguchi T; Matsumura H; Yamamoto K; Tsuruta H; Yata Y; Nishi H; Okamoto K; Kitamura K; Takahashi T
    Br J Cancer; 1996 Aug; 74(4):597-602. PubMed ID: 8761376
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A murine model for antibody-directed targeting of vascular endothelial cells in solid tumors.
    Burrows FJ; Watanabe Y; Thorpe PE
    Cancer Res; 1992 Nov; 52(21):5954-62. PubMed ID: 1394221
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.